Journals / Turkish Journal of Anaesthesiology and Reanimation / 2019 / Cilt: 47 - Sayı: 3

Anaesthetic Management for Face Transplantations: The Experience of Akdeniz University

Pages
228–234
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Side effects and complications may be reduced by strict follow-up and haemodynamic monitoring of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Solid organ transplantation is a rescue therapy, whereas face transplantation, as well as other composite tissue allotransplantations,offers treatment options to enhance the quality of life.
📊
Key Findings & Data:The pitfalls encountered before, during and following surgery were then summarised.Results: Two of our patients (patients 3 and 4) underwent permanent tracheostomy preoperatively.
💡
Conclusion & Impact:Side effects and complications may be reduced by strict follow-up and haemodynamic monitoring of patients.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Solid organ transplantation is a rescue therapy, whereas face transplantation, as well as other composite tissue allotransplantations,offers treatment options to enhance the quality of life. Difficult airway, severe haemorrhage and prolonged operative length are among the frequently encountered complications of anaesthetic management in patients with a history of multiple reconstructive surgeries.Methods: Five face allotransplants that were performed in our institute, arising from four full and one partial face transplantations, were reviewed. The pitfalls encountered before, during and following surgery were then summarised.Results: Two of our patients (patients 3 and 4) underwent permanent tracheostomy preoperatively. Transplantation was initiated after surgicaltracheostomy under local anaesthesia and under sedation in cases 2 and 5. Patient 1 was orally intubated without difficulty under general anaesthesia and was operated following tracheal cannulation via surgical tracheostomy. Thirteen units of red blood cells were transfused each forpatients 2 and 4. Two other patients (patients 1 and 4) each received 5 units of red blood cells. Patient 5, who underwent mid-face transplantationlasting for 7.5 h, was not transfused. No major life-threatening complications were observed intraoperatively or following surgery.Conclusion: Face transplantation is a surgical procedure in which anaesthetic management may be problematic. The anaesthetist may encounter difficulties, such as difficult airway, severe bleeding, a prolonged operative time and postoperative complications. Side effects and complications may be reduced by strict follow-up and haemodynamic monitoring of patients.

🔖

Cite This Article

HADİMİOĞLU, N., CENGİZ, M., RAMAZANOĞLU, A., ÖZKAN, Ö., ERTOSUN, M. G., ÖZKAN, Ö. (2019). Anaesthetic Management for Face Transplantations: The Experience of Akdeniz University. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 47 - Sayı: 3, 228–234. https://ajindex.com/articles/370161

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Watson CJ, Dark JH. Organ transplantation: historical perspective and current practice. Br J Anaesth 2012; 108(Suppl 1): i29-42
  2. Agich GJ, Siemionow M. Until they have faces: the ethics of facial allograft transplantation. J Med Ethics 2005; 31: 707-9. [CrossRef] 3. Devauchelle B, Badet L, Lengele B, Morelon E, Testelin S, Michallet M, et al. First human face allograft: early report. Lancet 2006; 368: 203-9. [CrossRef] 4. Guo S, Han Y, Zhang X, Lu B, Yi C, Zhang H, et al. Human facial allotransplantation: a 2-year follow-up study. Lancet 2008; 372: 631-8. [CrossRef] 5. Lantieri L, Meningaud JP, Grimbert P, Bellivier F, Lefaucheur JP, Ortonne N, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 2008; 372: 639-45. [CrossRef] 6. Siemionow M, Papay F, Alam D, Bernard S, Djohan R, Gordon C, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009; 374: 203-9. [CrossRef] 7. Ozkan O, Ozkan O, Ubur M, Hadimioglu N, Cengiz M, Afsar I. Face allotransplantation for various types of facial disfigurements: A series of five cases. Microsurgery 2017. DOI: 10.1002/micr.30272. [CrossRef] 8. Infante-Cossio P, Barrera-Pulido F, Gomez-Cia T, Sicilia-Castro D, Garcia-Perla-Garcia A, Gacto-Sanchez P, et al. Facial transplantation: a concise update. Med Oral Patol Oral Cir Bucal 2013; 18: e263-71
  3. Smeets R, Rendenbach C, Birkelbach M, Al-Dam A, Grobe A, Hanken H, et al. Face transplantation: on the verge of becoming clinical routine? Biomed Res Int 2014; 907272
  4. Sosin M, Rodriguez ED. The Face Transplantation Update: 2016. Plast Reconstr Surg 2016; 137: 1841-50. [CrossRef] 11. Sedaghati-nia A, Gilton A, Liger C, Binhas M, Cook F, Ait-Mammar B, et al. Anaesthesia and intensive care management of face transplantation. Br J Anaesth 2013; 111: 600-6. [CrossRef] 12. Dalal A. Face transplantation: Anesthetic challenges. World J Transplant 2016; 6: 646-9. [CrossRef] 13. Edrich T, Cywinski JB, Colomina MJ, Jimenez Lopez I, Xiong L, Sedaghati A, et al. Perioperative management of face transplantation: a survey. Anesth Analg 2012; 115: 668-70. [CrossRef]